eNauka - pregled

Pregled prema Autor Boehnke, Axel

Prikaz rezultata 1 do 6 od 6
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2017Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trialDavies, Andrew; Merli, Francesco; Mihaljevic, Biljana S ; Mercadal, Santiago; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; Genevray, Magali; Zharkov, Artem;
Dixon, Mark; Brewster, Michael; Barrett, Martin; MacDonald, David;
Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2013Pharmacokinetics (PK), safety and overall response rate (ORR) achieved with subcutaneous (SC) administration of rituximab in combination with chemotherapy were comparable to those achieved with intravenous (IV) administration in patients (pts) with follicDavies, AJ; Merli, Francesco; Mihaljevic, Biljana S ; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; McIntyre, Christine; Barrett, M; MacDonald, DKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2012Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with FollicDavies, Andrew J; Merli, Francesco; Mihaljevic, Biljana S ; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; McIntyre, Christine; Barrett, Martin; Macdonald, DavidKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2014Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 studyDavies, Andrew; Merli, Francesco; Mihaljević, Biljana ; Siritanaratkul, Noppadol; Solal-Céligny, Phillippe; Barrett, Martin; Berge, Claude; Bittner, Beate; Boehnke, Axel; McIntyre, Christine;
MacDonald, David;
Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2014Subcutaneous Rituximab and Chemotherapy Achieves Similar Overall Response Rates to Intravenous Rituximab in First-Line Follicular Lymphoma: Efficacy and Safety Results of the Phase Iii Sabrina StudyDavies, A; Merli, Francesco; Mihaljevic, Biljana S ; Mercadal, Santiago; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; Cambon, N; Macgregor, L; Brewster, M;
Barrett, M; MacDonald, D;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2013Subcutaneous Rituximab and Chemotherapy Achieves Similar Trough Levels, Safety, and Response as Intravenous Rituximab in First-Line Follicular Lymphoma: Stage 1 Results of the Phase 3 Sabrina StudyDavies, Andrew; Merli, Francesco; Mihaljevic, Biljana S ; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; McIntyre, Christine; Barrett, Martin; Macdonald, DavidKonferencijski rad
Mp kategorija će biti prikazana naknadno.